294 related articles for article (PubMed ID: 11460425)
1. [Chronic bronchitis. Gold standard from the internet].
MMW Fortschr Med; 2001 Jun; 143(23):47. PubMed ID: 11460425
[No Abstract] [Full Text] [Related]
2. [Clinical aspects of anticholinergic agents].
Friedman M
Rev Mal Respir; 1998 Sep; 15 Suppl 2():S51-4. PubMed ID: 9809345
[No Abstract] [Full Text] [Related]
3. beta-adrenergic receptor genotype and response to salmeterol.
Wechsler ME; Israel E
J Allergy Clin Immunol; 2007 Jul; 120(1):218-9; author reply 219-20. PubMed ID: 17399776
[No Abstract] [Full Text] [Related]
4. [Use of delayed-action beta-2 mimetics in the management of chronic obstructive bronchial diseases--for].
Muir JF; Cuvelier A
Rev Mal Respir; 1999 Jan; 16 Suppl 3():S75-6. PubMed ID: 10088257
[No Abstract] [Full Text] [Related]
5. Choice of bronchodilator therapy for patients with COPD.
Wedzicha JA
N Engl J Med; 2011 Mar; 364(12):1167-8. PubMed ID: 21428773
[No Abstract] [Full Text] [Related]
6. Choice of bronchodilator therapy in chronic obstructive pulmonary disease.
Rennard SI
Respirology; 1997; 2 Suppl 1():S11-5. PubMed ID: 9400689
[TBL] [Abstract][Full Text] [Related]
7. Long-acting beta agonists--prescribe with care.
Crane J
N Z Med J; 2006 Jul; 119(1237):U2064. PubMed ID: 16862206
[No Abstract] [Full Text] [Related]
8. Combination bronchodilator therapy in COPD.
Rennard SI
Chest; 1995 May; 107(5 Suppl):171S-175S. PubMed ID: 7743822
[No Abstract] [Full Text] [Related]
9. The value of early diagnosis for effective management of chronic obstructive pulmonary disease.
Doherty DE; Chapman KR; Martinez FJ; Belfer MH
J Fam Pract; 2007 Oct; 56(10 Suppl Value):S1-24. PubMed ID: 17949606
[No Abstract] [Full Text] [Related]
10. [The MMW Drug Prize 2002: Prize for a new classic with innovation potential].
Schultze-Werninghaus G
Med Klin (Munich); 2002 Dec; 97 Suppl 2():1. PubMed ID: 12593173
[No Abstract] [Full Text] [Related]
11. Treatment of chronic obstructive pulmonary disease: Combination or component therapy?
Hackam DG
CMAJ; 2003 May; 168(10):1296-7. PubMed ID: 12743078
[No Abstract] [Full Text] [Related]
12. [Chronic obstructive pulmonary disease. No increased survival with combination therapy].
Ecker-Schlipf B
Med Monatsschr Pharm; 2007 Nov; 30(11):428-9. PubMed ID: 18062342
[No Abstract] [Full Text] [Related]
13. Bronchodilator therapy in chronic obstructive pulmonary disease.
Manning HL
Curr Opin Pulm Med; 2000 Mar; 6(2):99-103. PubMed ID: 10741767
[TBL] [Abstract][Full Text] [Related]
14. Best evidence topic reports. Beta-agonists with or without anti-cholinergics in the treatment of acute childhood asthma?
Munro A; Maconochie I
Emerg Med J; 2006 Jun; 23(6):470. PubMed ID: 16714513
[No Abstract] [Full Text] [Related]
15. [Management of patients with chronic obstructive pulmonary disease].
Coll R; Morera J
Rev Clin Esp; 1994 Dec; 194(12):1049-57. PubMed ID: 7863055
[No Abstract] [Full Text] [Related]
16. Rebuttal: should we avoid beta-agonists for moderate and severe chronic obstructive pulmonary disease? Yes.
Salpeter SR
Can Fam Physician; 2007 Sep; 53(9):1429-30, 1432-3. PubMed ID: 17872865
[No Abstract] [Full Text] [Related]
17. A combination with clinical recommended dosages of salmeterol and ipratropium is not more effective than salmeterol alone in patients with chronic obstructive pulmonary disease.
Matera MG; Caputi M; Cazzola M
Respir Med; 1996 Sep; 90(8):497-9. PubMed ID: 8869445
[No Abstract] [Full Text] [Related]
18. Prevention of death in COPD.
La Vecchia C; Fabbri LM
N Engl J Med; 2007 May; 356(21):2211-2; author reply 2213-4. PubMed ID: 17526088
[No Abstract] [Full Text] [Related]
19. Bronchodilator resuscitation in the emergency department. Part 2 of 2: dosing strategies.
Fink J; Dhand R
Respir Care; 2000 May; 45(5):497-512. PubMed ID: 10813227
[No Abstract] [Full Text] [Related]
20. [Drug therapy of airway obstruction. "Completely different for asthma and COPD"].
MMW Fortschr Med; 2008 May; 150(20):14, 16. PubMed ID: 18605635
[No Abstract] [Full Text] [Related]
[Next] [New Search]
